Summary: BRAIN-funded investigator, Dr. Gabriel Lázaro-Muñoz, discusses ethical questions surrounding what happens to clinical trial participants when the trial ends but participants are benefiting from treatment.
Dr. Gabriel Lazaro-Munoz, assistant professor in the Center for Medical Ethics and Health Policy at Baylor
In the Press
04/24/2018
Ethicists: access needed after brain implant clinical trials
BY:
